Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Bioiberica","sponsor":"Bayer AG","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Strategic Distribution Between Bayer Animal Health and Bioiberica in the International Companion Animal Health Market","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Approved","country":"SPAIN","productType":"Small molecule","productStatus":"Approved","date":"June 2020","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Approved"},{"orgOrder":0,"company":"Bioiberica","sponsor":"ByHealth","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"New Partnership With ByHealth in China","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Approved","country":"SPAIN","productType":"Large molecule","productStatus":"Approved","date":"March 2022","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Approved"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Apsen","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product\u2013Motilex HA","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Approved","country":"SPAIN","productType":"Small molecule","productStatus":"Approved","date":"April 2021","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Approved"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Nestle Health Sciences SA","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Nestl\u00e9 Health Science Partners with Bioiberica to Deliver Innovative Nutrition in Joint Health and Mobility","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Undisclosed","country":"SPAIN","productType":"Small molecule","productStatus":"Approved","date":"June 2020","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Undisclosed"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"New Study Reveals Bioiberica's Dermial\u00ae Delivers Superior Benefits for Skin Health","therapeuticArea":"Dermatology","highestDevelopmentStatus":"Preclinical","country":"SPAIN","productType":"Small molecule","productStatus":"Approved","date":"May 2022","url1":"","url2":"","graph1":"Dermatology","graph2":"Preclinical"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"New Study Further Validates Bioiberica\u2019s B-2cool\u00ae Native Type II Collagen as Trusted Source for Holistic Mobility Solutions","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Approved","country":"SPAIN","productType":"Large molecule","productStatus":"Approved","date":"September 2020","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Approved"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Approved","country":"SPAIN","productType":"Small molecule","productStatus":"Approved","date":"July 2021","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Approved"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Laboratorios Ordesa Incorporates B-2cool\u00ae, Bioiberica\u2019s Native Type II Collagen, in Its New Colnatur\u00ae Forte","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Approved","country":"SPAIN","productType":"Large molecule","productStatus":"Approved","date":"July 2020","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Approved"}]

    Find Clinical Drug Pipeline Developments & Deals by Bioiberica

    Menu

    Bioiberica

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Bioiberica

              Contact Supplier
              • Development Update
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health

              Details:

              New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.

              Lead Product(s): Hyaluronic Acid,Dermatan Sulfate,Collagen

              Therapeutic Area: Dermatology Product Name: Dermial

              Highest Development Status: Preclinical Product Type: Small molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable May 25, 2022

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica

              Contact Supplier
              • Deals
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              New Partnership With ByHealth in China

              Details:

              By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient products across the country.

              Lead Product(s): Undenatured Type II Collagen

              Therapeutic Area: Musculoskeletal Product Name: Collavant n2

              Highest Development Status: Approved Product Type: Large molecule

              Partner/Sponsor/Collaborator: ByHealth

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership March 11, 2022

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica

              Contact Supplier
              • Development Update
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare

              Details:

              Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.

              Lead Product(s): Chondroitin Sulfate

              Therapeutic Area: Musculoskeletal Product Name: CSbioactive

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable July 05, 2021

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica

              Contact Supplier
              • Deals
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product–Motilex HA

              Details:

              Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint function.

              Lead Product(s): Hyaluronic Acid,Type II Collagen

              Therapeutic Area: Musculoskeletal Product Name: Motilex HA

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Apsen

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership April 26, 2021

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica

              Contact Supplier
              • Development Update
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              New Study Further Validates Bioiberica’s B-2cool® Native Type II Collagen as Trusted Source for Holistic Mobility Solutions

              Details:

              The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract rich in hyaluronic acid.

              Lead Product(s): Undenatured Type II Collagen,Chondroitin Sulfate,Hyaluronic Acid

              Therapeutic Area: Musculoskeletal Product Name: Mobilee

              Highest Development Status: Approved Product Type: Large molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable September 07, 2020

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica

              Contact Supplier
              • Development Update
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Laboratorios Ordesa Incorporates B-2cool®, Bioiberica’s Native Type II Collagen, in Its New Colnatur® Forte

              Details:

              B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.

              Lead Product(s): Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid

              Therapeutic Area: Musculoskeletal Product Name: Colnatur Forte

              Highest Development Status: Approved Product Type: Large molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable July 15, 2020

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica

              Contact Supplier
              • Deals
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Nestlé Health Science Partners with Bioiberica to Deliver Innovative Nutrition in Joint Health and Mobility

              Details:

              Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix.

              Lead Product(s): Hyaluronic Acid,Type II Collagen,Polysaccharide

              Therapeutic Area: Musculoskeletal Product Name: Meritene Mobilis

              Highest Development Status: Undisclosed Product Type: Small molecule

              Recipient: Nestle Health Sciences SA

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership June 16, 2020

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica

              Contact Supplier
              • Deals
              Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
              Contact Supplier Contact Supplier
              Flag Spain
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Strategic Distribution Between Bayer Animal Health and Bioiberica in the International Companion Animal Health Market

              Details:

              Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.

              Lead Product(s): Chondroitin Sulfate,Glucosamine,Hyaluronic Acid

              Therapeutic Area: Musculoskeletal Product Name: Condrovet

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: Bayer AG

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement June 09, 2020

              Bioiberica Company Banner

              CPhI Worldwide, Milan

              Booth #3A94

              envelop Contact Supplier

              Bioiberica VB Read More
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY